Page 6 - Johnson & Johnson

J&J confirms pausing Covid-19 vaccine trial because of unexplained illness

Earlier this month, Johnson & Johnson joined the short list of vaccine makers that have moved an experimental coronavirus shot into late-stage human studies

J&J Covid-19 vaccine produces strong immune response in early trials

A leading Covid-19 vaccine candidate developed by global healthcare company Johnson & Johnson produced a strong immune response against novel coronavirus in early-to-mid stage clinical trials, a report said.

World Coronavirus Dispatch: J&J announces final stage trials of vaccine

French biz confidence up despite resurgence, China eases entry rules for some foreigners, tough times for airlines as attempts to reopen falter, and other pandemic-related news across the globe

Johnson & Johnson kicks off giant study of single shot Covid-19 vaccine

J&J became the fourth vaccine maker to move its candidate into late-stage human studies in the US

Trump suggests Pfizer could win first US approval for Covid-19 vaccine

'Pfizer's doing really well', Trump said in an interview

Johnson & Johnson to buy Momenta Pharmaceuticals for $6.5 billion

The deal is the latest sign drug companies are looking for ways to bulk up even as the coronavirus pandemic upends other businesses

Britain lines up more potential Covid-19 vaccines with J&J, Novavax deals

Britain and the United States are in the lead with six vaccine deals with drugmakers each, as companies and governments worldwide work overtime to find a vaccine against the pandemic disease

Hyderabad-based Biological E joins hands with J&J for Covid-19 vaccine

The vaccine candidate is in phase 1/2a clinical trials

US inks $1.5 bn deal with Moderna for 100 mn doses of Covid-19 'vaccine'

The US government previously gave Moderna around $1 billion to fund its research efforts, bringing total US funding to around $2.5 billion

Johnson & Johnson's Covid-19 vaccine protected monkey in single shot

A leading candidate of Covid-19 vaccine developed by global healthcare company Johnson & Johnson raised neutralising antibodies and robustly protected monkeys against SARS-CoV-2, the virus that causes Covid-19.

Emergent signs 5-year deal to make drug used in J&J's Covid-19 vaccine

The news follows a $135 million deal struck by the two companies in April, to use Emergent's manufacturing facilities to speed up the development and production of its vaccine candidate

J&J loses bid to overturn baby powder verdict, but damages cut to $2.12 bn

The Missouri Court of Appeals lowered the original $4.69 billion verdict from July 2018 after dismissing claims by some of the 22 women and their families who had sued

J&J sets aside fairness business to stand with #BlackLivesMatter movement

Now with J&J taking its brand out of the game, other brands have a larger slice of the pie to carve out, but is there a risk in doing that?

J&J to begin human trials of Covid-19 vaccine in second half of July

The company has already signed deals with the US government to create enough manufacturing capacity to produce more than 1 billion doses of its vaccine through 2021

Johnson & Johnson to stop selling talc-based baby powder in US, Canada

J&J faces about 19,400 cases alleging its talcum powder caused users to develop ovarian cancer, through use for feminine hygiene, or mesothelioma, a cancer that strikes the lungs and other organs

J&J to stop selling baby powder in US, Canada after portfolio reassessment

J&J faces more than 16,000 lawsuits from consumers claiming its talc products, including Johnson's Baby Powder, caused their cancer

Johnson & Johnson expects human trial of its Covid-19 vaccine by September

Through a partnership, the Biomedical Advanced Research and Development Authority (BARDA) and Johnson & Johnson together have committed more than $1 billion of investment to co-fund vaccine research

Johnson & Johnson says no evidence of HIV drug working against Coronavirus

The company said it was aware that HIV treatments are being considered as options to treat patients diagnosed with COVID-19, a disease caused by the coronavirus

J&J sees high demand for consumer products as Coronavirus spreads

J&J said majority of its global medical device manufacturing was running at or near normal capacity, and that it does not expect the outbreak to cause any disruptions to its supply of medicines.

J&J ordered by Florida jury to pay $9 million in talc-cancer case

The talc litigation may eventually cost the company as much as $10 billion, according to Bloomberg Intelligence